Question 500
A health analytics startup is offered a proprietary data ingestion service, but contracts omit export formats and termination assistance. Which limitation must be considered before claiming the issue is fully resolved?
Explanation
Correct Answer
A low introductory price can conceal high switching and egress costs. This caution prevents extrapolating beyond the specific evidence or product boundary. Vendor evaluation should account for reversibility and lifecycle economics. The unresolved point should be tested using contract exit provisions, export capabilities and portability proof-of-concept rather than assuming a working interface proves full compliance or resilience.
Incorrect Answers
A documented API implies the provider offers full export on termination. This limitation is framed as a blanket exception, but the case requires a different, narrower caution. The relevant boundary is that a low introductory price can conceal high switching and egress costs. Vendor evaluation should account for reversibility and lifecycle economics. Inspect contract exit provisions, export capabilities and portability proof-of-concept.
A vendor contract's uptime target guarantees painless data portability. The proposed claim mistakes an incomplete signal or product feature for a universal guarantee. The relevant boundary is that a low introductory price can conceal high switching and egress costs. Vendor evaluation should account for reversibility and lifecycle economics. Inspect contract exit provisions, export capabilities and portability proof-of-concept.
An agreed SLA prevents data egress charges and export limitations. This claim exceeds the evidence and ignores an important risk or operational dependency. The relevant boundary is that a low introductory price can conceal high switching and egress costs. Vendor evaluation should account for reversibility and lifecycle economics. Inspect contract exit provisions, export capabilities and portability proof-of-concept.